Jim Simons Alx Oncology Holdings Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 155,300 shares of ALXO stock, worth $257,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,300

Previous 438,200 64.56%

Holding current value

$257,798

Previous $2.64 Million 89.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.81 - $8.13 $512,049 - $2.3 Million	-282,900 Reduced 64.56%	155,300 $282,000
Q2 2024 Aug 09, 2024	BUY	$5.84 - $17.56 $1.19 Million - $3.58 Million	204,100 Added 87.18%	438,200 $2.64 Million
Q1 2024 May 13, 2024	SELL	$10.95 - $16.79 $398,580 - $611,156	-36,400 Reduced 13.46%	234,100 $2.61 Million
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $278,980 - $892,040	58,000 Added 27.29%	270,500 $4.03 Million
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $124,443 - $218,295	29,700 Added 16.25%	212,500 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $244,636 - $535,178	55,981 Added 44.14%	182,800 $1.37 Million
Q1 2023 May 12, 2023	BUY	$4.52 - $11.71 $140,205 - $363,232	31,019 Added 32.38%	126,819 $573,000
Q4 2022 Feb 13, 2023	SELL	$9.51 - $12.95 $711,348 - $968,660	-74,800 Reduced 43.85%	95,800 $1.08 Million
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $469,793 - $864,236	-57,083 Reduced 25.07%	170,600 $1.63 Million
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $464,620 - $1.54 Million	78,883 Added 53.01%	227,683 $1.84 Million
Q1 2022 May 13, 2022	SELL	$13.65 - $22.06 $260,715 - $421,346	-19,100 Reduced 11.38%	148,800 $2.52 Million
Q4 2021 Feb 11, 2022	BUY	$21.49 - $74.4 $3.61 Million - $12.5 Million	167,900 New	167,900 $3.61 Million

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $67.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account